141 related articles for article (PubMed ID: 34474856)
1. Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.
Sharma S; Pukale S; Sahel DK; Singh P; Mittal A; Chitkara D
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112305. PubMed ID: 34474856
[TBL] [Abstract][Full Text] [Related]
2. Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery.
Sharma S; Pukale SS; Sahel DK; Agarwal DS; Dalela M; Mohanty S; Sakhuja R; Mittal A; Chitkara D
AAPS PharmSciTech; 2020 Oct; 21(7):280. PubMed ID: 33037506
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
4. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
5.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery.
Sharma S; Mazumdar S; Italiya KS; Date T; Mahato RI; Mittal A; Chitkara D
Mol Pharm; 2018 Jun; 15(6):2391-2402. PubMed ID: 29747513
[TBL] [Abstract][Full Text] [Related]
7. pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.
Sui F; Fang Z; Li L; Wan X; Zhang Y; Cai X
Int J Pharm; 2023 Sep; 644():123293. PubMed ID: 37541534
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.
Zhang L; Yang X; Lv Y; Xin X; Qin C; Han X; Yang L; He W; Yin L
Sci Rep; 2017 Apr; 7():46186. PubMed ID: 28383524
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
13. pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel.
Swami R; Kumar Y; Chaudhari D; Katiyar SS; Kuche K; Katare PB; Banerjee SK; Jain S
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111664. PubMed ID: 33545830
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
[TBL] [Abstract][Full Text] [Related]
15. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
16. Tumour targeted polymer nanoparticles co-loaded with docetaxel and siCCAT2 for combination therapy of lung cancer.
Xiao D; Hu X; Zhang J
J Drug Target; 2022 Jun; 30(5):534-543. PubMed ID: 34931561
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
18. Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.
Nateghian N; Goodarzi N; Amini M; Atyabi F; Khorramizadeh MR; Dinarvand R
Chem Biol Drug Des; 2016 Jan; 87(1):69-82. PubMed ID: 26216713
[TBL] [Abstract][Full Text] [Related]
19. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of Docetaxel.
Sohail MF; Hussain SZ; Saeed H; Javed I; Sarwar HS; Nadhman A; Huma ZE; Rehman M; Jahan S; Hussain I; Shahnaz G
Sci Rep; 2018 Sep; 8(1):13304. PubMed ID: 30190588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
